Autopsy report · NCT01023919
Assessment of Surface Coverage of Two Types of Drug-eluting Stent in Diabetes Mellitus and Non-Diabetes Mellitus
Cause of deathSlow enrollment
“Difficulty in enrolling the required number of participants has made it impractical to proceed with the trial.”
Life of this trial
- Ran for about 1 year 1 month before it stopped.
- 120 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Harbin Medical University
- Sponsor type
- University, hospital or other
- Conditions
- Coronary Artery Disease; Diabetes Mellitus
- Interventions
- Device: Polymer-based sirolimus-eluting stent(Cypher stent ) and Polymer-free paclitaxel-eluting stent (YinYi stent)
- Participants
- 120
- Sites
- 1
- Countries
- China
Trials that died the same way
- Evaluation of the Cryopreserved Amniotic Membranes in the Care of Resistant Vascular Ulcers
“clinical trial have encountered difficulties enrolling a sufficient number of patients” - Prostatic Artery Embolization for the Treatment of Lower Urinary Tract Symptoms in Prostate Cancer Patients Undergoing Radiation Therapy
“Enrolling to this clinical trial was too difficult” - Regulation of LncRNA For Breg in Patients With Thymoma and Autoimmune Diseases
“Improper design of the trial and no participants enrolled.” - Neoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage HCC: a Multi-center Randomized Controlled Trial.
“Difficult to enroll participants” - Efficacy and Safety of Empagliflozin in NODAT
“Difficult in enrolling suitable participants”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.